Risk undermined in the bilateral pharmaceutical regulatory system in Taiwan

by Hui-Po Wang, Chun-Li Wang
Published 2018-04-01

Efficacy of Azatyrosine-Phenylbutyric Hydroxamides, a Histone Deacetylase Inhibitor, on Chemotherapy-Induced Gastrointestinal Mucositis

by Po-Lin Liao, Shih-Hsuan Huang, Chien-Hung Hung, Wei-Kuang Huang, Chi-Hao Tsai, Jaw-Jou Kang, Hui-Po Wang, Yu-Wen Cheng
Published 2019-01-01

Association of ORAI1 haplotypes with the risk of HLA-B27 positive ankylosing spondylitis.

by James Cheng-Chung Wei, Jeng-Hsien Yen, Suh-Hang Hank Juo, Wei-Chiao Chen, Yu-Shiuan Wang, Yi-Ching Chiu, Tusty-Jiuan Hsieh, Yuh-Cherng Guo, Chun-Huang Huang, Ruey-Hong Wong, Hui-Po Wang, Ke-Li Tsai, Yang-Chang Wu, Hsueh-Wei Chang, Edward Hsi, Wei-Pin Chang, Wei-Chiao Chang
Published 2011-01-01

1.Study on Synthesis of Hypolipoproteinemic Agent Gemfibrozil

by Kai-Der Ker, 柯開德
Published 1994

Pharmacokinetic studies on di- and tri-peptide mimetic L-Dopa analogues

by Lei Sai-Ian, 李世恩
Published 1999

Synthesis and stability study of beta-lactam oral prodrugs

by Chi-hua Sung, 宋啟華
Published 1996

Pharmacokinetic Studies on TW01

by Wei-Hsien Hsieh, 謝緯賢
Published 2003

Study on Solubility Optimization of A Novel Anti-mucositis Agent Aza-PBHA

by Wei-Chen Lin, 林惟晨
Published 2013